For the TransCon CNP-treated cohort (average treatment of 2.56 years), mean AGV was 8.42 cm/year, representing an increase from baseline at Week 52 of 3.28 cm/year, with an improvement in mean ACH ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback